Stockholder rights law firm Bragar Eagel & Squire is investigating potential claims against Clarianton behalf of Clariant stockholders. The investigation concerns whether Clariant has violated the federal securities laws and/or engaged in other unlawful business practices.

On February 14, 2022, Swiss chemical maker, Clariant AG, disclosed that it will delay issuing Q4 2021 and full year 2021 financial results due an ongoing internal investigation into potential accounting fraud.

Clariant AG is investigating internal whistleblower complaints that the company has known about since September 2021, pertaining to booking issues aimed at boosting results to meet targets.

On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.